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On Feb. 21 in Havana, Raul Taladrid, vice president of the State Economic Cooperation Committee
(Comite Estatal de Colaboracion Economica-CECE), reported that the government had concluded
two agreements with the UN Development Programme (UNDP) focused on coordinating technical
assistance and financing for biotechnology research and production. The accords were signed by
Taladrid and UNDP representative Joachim von Boraunmuhl. According to Taladrid, the Cuban
government's contribution to the projects totals over 15 million pesos (at the official exchange rate,
equivalent to about US$15 million), and the UNDP's, US$2.6 million. Under one of the accords, the
UNDP is to contribute funding for equipment at a single-cell antibody research and production
facility. The antibodies are described as cutting edge biotechnology applications in diagnostics,
and treatment of cancer, immuno-deficiencies (including AIDS), infectious and cardiac diseases,
and organ transplant rejection. Next, the agreements include a pilot project for the semi-industrial
production via fermentation of active base material, bio-catalysts, and medicines. Most of these
materials are currently imported. [Basic data from Agencia de Informacion Nacional (Cuba),
Spanish news service EFE, 02/21/92]
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